The Inflammasome in Atherosclerosis and Type 2 Diabetes
- 4 May 2011
- journal article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 3 (81), 81ps17
- https://doi.org/10.1126/scitranslmed.3001902
Abstract
Type 2 diabetes and atherosclerosis might be linked through the inflammasome via obesity-related triggers.Keywords
This publication has 82 references indexed in Scilit:
- The Inflammasome-Mediated Caspase-1 Activation Controls Adipocyte Differentiation and Insulin SensitivityCell Metabolism, 2010
- Engagement of fatty acids with toll‐like receptor 2 drives interleukin‐1β production via the ASC/caspase 1 pathway in monosodium urate monohydrate crystal–induced gouty arthritisArthritis & Rheumatism, 2010
- NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystalsNature, 2010
- The InflammasomesCell, 2010
- Toxic oligomers and islet beta cell death: guilty by association or convicted by circumstantial evidence?Diabetologia, 2010
- The inflammasomes: mechanisms of activation and functionCurrent Opinion in Immunology, 2010
- Reduced Apoptosis and Plaque Necrosis in Advanced Atherosclerotic Lesions of Apoe−/− and Ldlr−/− Mice Lacking CHOPCell Metabolism, 2009
- Treatment with an Interleukin 1 beta antibody improves glycemic control in diet-induced obesityCytokine, 2008
- Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilizationNature Immunology, 2008
- Toll-like receptor 2 plays a critical role in the progression of atherosclerosis that is independent of dietary lipidsAtherosclerosis, 2007